Showing results (41-50 of 104) with videos related to
Sort By:
Pageof 11
The New Microbiologica|January 22, 2024
Optimizing the antiretroviral treatment focusing on long-term effectiveness and a person-centered approach. Consensus Guidance Using a Delphi ProcessFranco Maggiolo, Sergio Lo Caputo, Stefano Bonora, et al.The Journal of Antimicrobial Chemotherapy|September 23, 2025
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohortAlessandra Vergori, Alessandro Cozzi-Lepri, Sergio Lo Caputo, et al.Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|May 7, 2025
Covid-19 and Mortality in Chronic Hemodialysis Patients: Cause or Mere Concomitance? The Experience of Policlinico GemelliMartina Ambrogio, Luigi Cappannoli, Erica Rosati, et al.HIV Medicine|April 28, 2025
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohortAndrea De Vito, Alessandro Tavelli, Alessandro Cozzi-Lepri, et al.AIDS (London, England)|August 30, 2008
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysisAndrea De Luca, Adriana Ammassari, Patrizio Pezzotti, et al.Journal of Personalized Medicine|June 28, 2023
Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19Maria Camilla Cipriani, Cristina Pais, Vezio Savoia, et al.Sexually Transmitted Infections|March 24, 2026
Medical and psychological needs for injectable long-acting cabotegravir as pre-exposure prophylaxisRoberto Rossotti, Alessandra Bianchi, Alessandro Tavelli, et al.The Journal of Antimicrobial Chemotherapy|January 31, 2025
Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIVLucia Taramasso, Stefano Bonora, Antonella Cingolani, et al.Journal of Medical Virology|September 27, 2023
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trialElena Bruzzesi, Arianna Gabrieli, Davide Bernasconi, et al.AIDS Research and Human Retroviruses|January 24, 2002
Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphomaLucia Fassone, Antonella Cingolani, Maurizio Martini, et al.Pageof 11